Laure Ory-Lavollée
Keine laufenden Positionen mehr
Karriereverlauf von Laure Ory-Lavollée
Ehemalige bekannte Positionen von Laure Ory-Lavollée
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Diatos SA
 Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Direktor/Vorstandsmitglied | - | 15.09.2009 |
| Puilaetco | Analyst-Equity | 15.05.2002 | 15.05.2002 |
| CELLECTIS S.A. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
| Frankreich | 3 |
| 2 |
Operativ
| Director/Board Member | 2 |
| Analyst-Equity | 1 |
Sektoral
| Health Technology | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Diatos SA
Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Health Technology |
| Puilaetco | Finance |
- Börse
- Insiders
- Laure Ory-Lavollée
- Erfahrung
